Cargando…
Canine Albumin Polymorphisms and Their Impact on Drug Plasma Protein Binding
Drug binding to plasma proteins is routinely determined during drug development. Albumin polymorphisms c.1075G>T (p.Ala359Ser) and c.1422A>T (p.Glu474Asp) were previously shown to alter plasma protein binding of a drug candidate (D01-4582, 4-[1-[3-chloro-4-[N′-(2-methylphenyl)ureido]phenylacet...
Autores principales: | Costa, Ana P., Court, Michael H., Burke, Neal S., Zhu, Zhaohui, Mealey, Katrina L., Villarino, Nicolas F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744390/ https://www.ncbi.nlm.nih.gov/pubmed/31481400 http://dx.doi.org/10.1124/dmd.119.087304 |
Ejemplares similares
-
Canine and feline P‐glycoprotein deficiency: What we know and where we need to go
por: Mealey, Katrina L., et al.
Publicado: (2022) -
Heparin-binding proteins of canine seminal plasma
por: de Souza, Fabiana Ferreira, et al.
Publicado: (2006) -
A Structure-Based Model for Predicting Serum Albumin Binding
por: Lexa, Katrina W., et al.
Publicado: (2014) -
Interactive Association of Drugs Binding to Human Serum Albumin
por: Yang, Feng, et al.
Publicado: (2014) -
Impact of Albumin Binding Function on Pharmacokinetics and Pharmacodynamics of Furosemide
por: Klinkmann, Gerd, et al.
Publicado: (2022)